Innovia Medical Acquires DTR Medical to Expand Portfolio of Single-Use Sterile Surgical Instruments

On October 28, 2019, VCBeat (WeChat ID: vcbeat) learned from foreign media reports that Innovia Medical (“Innovia”) announced the acquisition of medical device company DTR Medical. No financial terms of the transaction were disclosed.

Following the completion of this acquisition, Innovia will continue to develop new surgical medical devices, providing patients with high-quality products and premium services. Furthermore, this acquisition has solidified the company’s leading position in the treatment of ophthalmic and otolaryngological conditions.

DTR Medical, established in 2005 and headquartered in Swansea, Wales, UK, is a surgical medical device company. The company is dedicated to the design and manufacture of single-use sterile surgical instruments for use in general or specialized surgical procedures. Currently, DTR Medical’s products are exported to more than 30 countries and regions worldwide, and the company is renowned for its superior product quality and consistent customer service.

DTR Medical’s innovative single-use sterile devices have received numerous awards. In December 2012, the company’s Rotating Cervical Biopsy Punch was honored with the MediWales Innovation Award. In addition to manufacturing single-use surgical instruments, DTR Medical also provides cleanroom laboratory facilities to numerous pharmaceutical companies and medical device developers.

Clinical advisory research by DTR Medical indicates that the cost of single-use surgical instruments is lower than that of reusable medical devices. On one hand, while the reprocessing costs for both are comparable, reusable medical devices carry potential risks of cross-contamination and surgical site infections. On the other hand, there is a high risk of damage to precision instruments, resulting in excessive maintenance expenses.

Innovia, founded in 1978 and headquartered in Minnesota, USA, is a specialized medical device company. The company primarily collaborates with medical professionals to enhance the standard of care and improve patients’ clinical outcomes. Innovia’s developed and manufactured medical devices significantly boost healthcare providers’ operational efficiency, driving advancements in fields such as ophthalmology, otolaryngology, and plastic surgery.

Terry Meredith, CEO of Innovia, stated, “This strategic acquisition will further strengthen Innovia’s global leadership in the ENT and ophthalmology markets. Additionally, we have expanded our operations in areas such as gynecology and general surgery.”

Andrew Davidson, Managing Director of DTR Medical, said, “We are delighted to partner with Innovia. This investment will help us continue to develop innovative surgical solutions and bring our products to the international market.”

Richard Salvage, Founder of DTR Medical, commented, “The team at DTR Medical is dedicated to delivering exceptional services with high clinical value to improve patient outcomes. It is crucial for us to partner with organizations that share our core values, and we look forward to working with Innovia to bring new products to market.”

(Compiled by Xu Xiaoxue)